Stocks
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 20261 Estimated net asset value of approximately $60 million and no debt outstanding as of June 30, 2026¹ Approximately 19.5 million shares outstanding on post 1-for-60 split basis as of July 6, 20261 NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder
About this update from Srx Health Solutions, Inc.
Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 2026 1 Estimated net asset value of approximately $60 million and no debt outstanding as of June 30, 2026¹ Approximately 19.5 million shares outstanding on post 1-for-60 split basis as of July 6, 2026 1 NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today provided shareholders with a preliminary update on certain balance sheet metrics and its capitalization structure following the recently completed acquisition of EMJX and share consolidation effectuated on July 6, 2026. "Following the completion of the EMJX acquisition and the elimination of all outstanding debt, we have entered the second half of 2026 with one of the strongest balance sheets in the Company's history," states Kent Cunningham, CEO. The Company's strengthened balance sheet provides significant financial flexibility to execute its long-term capital allocation strategy, and management does not anticipate the need for additional capital raises in the foreseeable future. Management remains focused on maintaining liquidity and balance sheet strength while deploying capital in a disciplined manner across investments in its operating companies, treasury optimization initiatives, strategic investments, and value-enhancing acquisitions with the objective of maximizing long-term shareholder value. Preliminary Balance Sheet & Capital Allocation Highlights 1 : Capital Allocation Framework SRX believes disciplined capital allocation is fundamental to long-term shareholder value creation. The Company intends to allocate capital across the following strategic priorities:
View stock analysis, news, and events for Srx Health Solutions, Inc.